The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma

The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma

Glioblastoma (GBM) is a devastating brain cancer with no effective treatment, and there is an urgent need for developing innovative biomarkers as well as therapeutic targets for better management of the disease. The membrane protein sortilin has recently been shown to participate in tumor cell invas...

Full description

Bibliographic Details
Main Authors: Mark Marsland, Amiee Dowdell, Sam Faulkner, Craig Gedye, James Lynam, Cassandra P. Griffin, Joanne Marsland, Chen Chen Jiang, Hubert Hondermarck
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
Glioblastoma
sortilin
cancer biomarkers
cancer therapeutic targets
Online Access:https://www.mdpi.com/2072-6694/15/9/2514

Internet

https://www.mdpi.com/2072-6694/15/9/2514

Similar Items